Brain membrane phospholipid alterations in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Brain membrane phospholipid alterations in Alzheimer's disease.

Brain membrane phospholipid alterations in Alzheimer's disease.

http://www.wikidata.org/entity/Q43743686

about

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle Mitochondria-associated ER membranes and Alzheimer disease Peroxisomes in brain development and function Dynamics and Cleavability at the alpha-cleavage site of APP(684-726) in different lipid environments Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry Hydration and lateral organization in phospholipid bilayers containing sphingomyelin: a 2H-NMR study Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids.Deregulation of sphingolipid metabolism in Alzheimer's disease.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's disease Peroxisomal alterations in Alzheimer's disease Brain lipidomes of subcortical ischemic vascular dementia and mixed dementia Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.Choline-containing phospholipids in microdissected human Alzheimer's disease brain senile plaque versus neuropil.Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APP and APP/PS1 Mouse Models of Alzheimer's Disease: Relationship with the Lack of Neurodegeneration?Mitofusin-2 knockdown increases ER-mitochondria contact and decreases amyloid β-peptide production Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease.DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.Analytical methods for (oxidized) plasmalogens: Methodological aspects and applications.Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.Phospholipase D in brain function and Alzheimer's disease.Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis.Upregulated function of mitochondria-associated ER membranes in Alzheimer disease ApoE4 upregulates the activity of mitochondria-associated ER membranes.Lipids and the pathogenesis of Alzheimer's disease: is there a link?Promotion of oxidative lipid membrane damage by amyloid beta proteins Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers.Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models.Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS).Serum sphingomyelins and ceramides are early predictors of memory impairment Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease.Perturbations of the straight transmembrane α-helical structure of the amyloid precursor protein affect its processing by γ-secretase.Peroxisomes: a nexus for lipid metabolism and cellular signaling.APP Function and Lipids: A Bidirectional Link.Plasma phospholipids identify antecedent memory impairment in older adults.Oxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.Current strategies in the discovery of small-molecule biomarkers for Alzheimer's disease.

P2860

Q21560953-DDA9EEEC-C206-41AB-AC72-4D9E1CB1DF71 Q24685655-9DE88334-BC0C-4A3C-86E9-3650906D327F Q26745495-08B6B003-A2EF-4C71-9E42-66EA8C483A70 Q26774697-CA3955A9-C98A-4819-8AB2-2519FED018B3 Q28384987-F3AF0556-F44B-4632-B40A-DF816E3A348E Q28391606-3CBC1950-DCE2-4280-A30E-E94E8E248E82 Q30814627-0D7E1056-6E23-4C3B-9F3F-4762129BF5A9 Q33257571-7FD518DC-065F-473D-AEC8-8B3CA11816EF Q33693061-94953592-7064-48EE-B9BF-4BC034CBBC35 Q33861622-C4F1D29D-9C0B-47AF-B717-11D6CBEAE017 Q33905478-008281BE-F990-4791-99B9-24C66868276C Q33906496-0F75E343-05AC-4F8B-B50B-6833C4EAE815 Q33915435-532D44D4-4F05-4C38-BE14-DE5E6D12A533 Q34421898-8BFEB256-4EC4-47F2-B32E-6751D37DB592 Q34460818-DB6A816A-DA51-4BB8-BD7D-6C1544EBF14E Q34527610-3CD9B4C0-B90F-4684-9F9F-43E978E0835A Q34626206-DEC2497D-6D5D-48E7-A288-772D40731475 Q35086073-BE822692-32D2-42AE-8AA0-EECBA3CB8FF1 Q35433358-02D6684D-F2FB-43F2-A6B2-AE726C544446 Q35438097-48D63DBC-A4AD-4A70-9470-5544A400C2BE Q35533292-39FAA7CF-A633-44DC-8281-240FF27C9D8A Q35555867-9A842729-1E84-4BB5-995C-F29374D8AD1B Q35893701-B2B67BA3-10A2-4715-AB12-0132974CEAB0 Q36102989-8D724E94-07FC-4F11-A295-A1BE879146B1 Q36382102-ADDF4BA6-4022-42EE-B2FD-0AF4A73985A1 Q36478666-9357023F-1386-474D-9F12-9C3D900A53DA Q36508071-8AB9838E-CA2B-4850-AFE0-22F0A39293BB Q36528165-01C4A5CD-31D9-4B8E-B176-8F864D972B32 Q36590043-351E8F05-5866-486C-8D8E-745AA1707A1E Q36768801-50A5A355-291C-4831-AD11-23A692622988 Q36835580-BAD6BC89-D12F-468D-92A7-0D7515F3008D Q37049048-8AC1C202-8BC6-4ED4-80C6-6DA0CB5618ED Q37437931-C4017056-62C3-4D9B-BECA-B3F9676D512B Q37550487-D10C8261-9D67-4823-A5C6-0FAA3B9EC855 Q37622586-A9E515C1-A73C-4C84-994F-E9C30391D31A Q37633445-7AE9CAB1-09F2-4F0E-8E57-268FE2862035 Q37692220-B2C9D548-E861-48AB-83C9-32246B4549E2 Q37714213-B399251F-C962-4ACC-A87D-1F12AEA35815 Q37847817-09FD51C3-0D97-411E-83E8-6461CC457BB1 Q37876426-30FAE52A-B83A-4D12-AD66-096B7859AEC2

P2860

Brain membrane phospholipid alterations in Alzheimer's disease.

http://www.wikidata.org/entity/Q43743686

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Brain membrane phospholipid alterations in Alzheimer's disease.

@en

Brain membrane phospholipid alterations in Alzheimer's disease.

@nl

type

label

Brain membrane phospholipid alterations in Alzheimer's disease.

@en

Brain membrane phospholipid alterations in Alzheimer's disease.

@nl

prefLabel

Brain membrane phospholipid alterations in Alzheimer's disease.

@en

Brain membrane phospholipid alterations in Alzheimer's disease.

@nl

P1433

Q43743686-8342B30C-0B91-4999-8B11-30B70954CCEA

P1476

Q43743686-37E7F5C7-DBC4-4498-A58A-3E6CC18F91F5

P2093

Q43743686-984A56A7-FC65-4CF5-BCC3-5F286331E192

Q43743686-98C85E15-857F-45BD-8E6F-B79241215F0D

Q43743686-9FC3CA7E-7974-40C5-A4E5-E49ABC5D8171

Q43743686-E9A7D379-C860-43D7-B612-34B0A277AC6F

P2888

Q43743686-6F8ECB5A-2D60-437B-99FB-8ABE4757E6AE

P304

Q43743686-2966268A-909D-4954-A0D2-1F84F31734B0

P31

Q43743686-CCE4D906-CAB8-4984-BC2E-C02A13ECD28E

P356

Q43743686-23E48CEE-331C-41DA-8DED-1EC415A72DF2

P433

Q43743686-D0EA6968-0818-4931-AF36-A78DD144A9EC

P478

Q43743686-2737CAE5-1580-47CF-8197-4DC1417C62B3

P577

Q43743686-83292255-7559-4876-823D-429B20B2A307

P6179

Q43743686-CE454B69-D15F-46B1-AB0A-982CCAA45F24

P698

Q43743686-DEB457DA-0114-4748-AD6A-3729FB5A41BC

P921

Q43743686-057AFC91-371D-4BF0-83DF-622F9543EB17

P356

A:1011603916962

P1433

Neurochemical Research

P1476

Brain membrane phospholipid alterations in Alzheimer's disease.

@en

P2093

J W Pettegrew

http://www.w3.org/2001/XMLSchema#string

K Panchalingam

http://www.w3.org/2001/XMLSchema#string

R J McClure

http://www.w3.org/2001/XMLSchema#string

R L Hamilton

http://www.w3.org/2001/XMLSchema#string

P2888

a:1011603916962

P304

771-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1011603916962

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2001-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047542537

http://www.w3.org/2001/XMLSchema#string

P698

11565608

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease